Identification of the Immuno Suppressive Characteristics of Glioma Patients by an Integrated Radio-immunological Approach

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

The most aggressive primary brain tumors in adults, glioblastomas, are characterized by a profound local and systemic immune suppression. During tumor progression, the infiltration of inflammatory leukocytes, especially of myeloid origin, endowed with immunosuppressive function is observed. Aim of this study is to evaluate myeloid cell infiltrate and iron metabolism in tumor-associated macrophages by combining a multimodal MRI imaging technique with immunophenotyping of the tumor microenvironment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• All patients with histologic confirmation of malignant glioma

• Patients must be age \>= 18 years

• Patients must be able to obtain an MRI scan with gadolinium contrast

• Patients must sign informed consent indicating that they are aware of the investigational nature of this study:

Locations
Other Locations
Italy
University Hospital
RECRUITING
Florence
University Hospital
RECRUITING
Padua
Contact Information
Primary
Susanna Mandruzzato, PhD
susanna.mandruzzato@unipd.it
+39 049 8215898
Time Frame
Start Date: 2022-02-23
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 40
Sponsors
Collaborators: Azienda Ospedaliero-Universitaria Careggi, Azienda Ospedaliera di Padova
Leads: Istituto Oncologico Veneto IRCCS

This content was sourced from clinicaltrials.gov